The study, published in The Lancet, found a possible association between hydroxychloroquine and chloroquine and heart arrhythmias and death. Meanwhile, SingleCare saw a as much as a 22% increase in scripts filled for hydroxychloroquine following Trump's remarks last week.
The announcement comes as researchers have noted that the pandemic has begun shifting from urban centers like New York to rural areas of the country. The U.S. continues to lead the world in SARS-CoV-2 infections, with more than 1.5 million cases as of Thursday.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Rick Bright's attorneys said in an emailed statement Friday that the Office of the Special Counsel would request a 45-day stay on Bright's removal as director of BARDA. Bright was removed over his objections to broad use of two malaria drugs in Covid-19.
Drugmakers, medical research groups and healthcare companies and organizations are at risk of "password spraying" attacks by state-sponsored hackers, the officials said in a joint statement.
Bloomberg reported Wednesday that the Trump administration is launching the effort, which it compared to the Manhattan Project, to shorten the length of time it would take to develop a vaccine for the disease.
Two reports published by the Office of the Inspector General shed light on why the VA pushed back its rollout of a new health record system. The OIG said the March 2020 deployment date was “likely unrealistic.”
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
A preprint retrospective analysis among 368 patients hospitalized with Covid-19 in the VA system found no benefit and a higher degree of death from hydroxychloroquine. A panel of experts also recommended against using the drug with azithromycin outside of trials due to potential toxicity.
Washington, California and New York passed emergency measures this week requiring insurers to cover the cost of care related to testing for COVID-19. Public health experts are urging insurers to waive costs related to coronavirus testing and treatment, in hopes that sick patients won't be deterred from seeking care.
More than 80,000 people worldwide have been infected with the SARS-CoV-2 virus. In response, the U.S. government has partnered with several companies to develop drugs to treat the infection and vaccines to prevent it.
In a joint statement, FDA Commissioner Stephen Hahn and FTC Chairman Joseph Simons said they would look into anticompetitive practices like preventing biosimilar makers from obtaining product samples and misleading communications about biosimilars' safety and efficacy.
We will highlight Build My Health's revenue practice management tools, which could help physician practices add up to $250,000 to their practices.
BIO's first annual report on diversity in the workplace found room for improvement, as biotech workforces - especially at the executive level - were found to not represent the U.S. population. The report was based on a survey of nearly 100 companies in late spring 2019.
Under the decision, Medicare patients with inherited cancer mutations such as BRCA will receive coverage for NGS testing. Drugs that treat BRCA-mutated breast and ovarian cancers include AstraZeneca's Lynparza and Pfizer's Talzenna.
The company is seeking approval for tucatinib, combined with two other drugs, for patients with HER2-positive breast cancer who have had at least three prior HER2-targeting therapies.
The FDA approved Padcev (enfortumab vedotin-ejfv), an antibody-drug conjugate for locally advanced or metastatic urothelial carcinoma, which marks the Seattle biotech's second regulatory approval.
The Senate voted 72-18 Thursday to confirm Hahn, a radiation oncologist and chief medical executive at The University of Texas MD Anderson Cancer Center.